Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis
Conclusion:
This study will provide comprehensive evidence for medical staff to adopt effective treatment strategies for breast cancer patients during the COVID-19 pandemic.
PROSPERO registration number:
CRD42020188208.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | China Health | Coronavirus | COVID-19 | Databases & Libraries | Internal Medicine | Pandemics | Radiation Therapy | Science | Study